Literature DB >> 12698107

Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling.

Huaizhong Hu1, Yinchen Dong, Ping Feng, John Fechner, Majed Hamawy, Stuart J Knechtle.   

Abstract

BACKGROUND: The in vivo effects of immunosuppressants on T cells are classically determined using animal models of organ transplantation. These methods are technically difficult and time consuming. A simple in vivo method is needed for screening new immunosuppressants.
METHODS: Donor mouse spleen cells were labeled with a fluorescent dye, carboxy-fluorescein diacetate succinimidyl ester (CFSE), and then injected into the blood of recipient severe combined immunodeficiency mice. Three days after the injection, spleen cells of the recipient mice were isolated and the proliferating alloreactive T cells were analyzed by flow cytometry.
RESULTS: In control recipient mice, 50% of the T cells were proliferating, consisting of both CD4+ and CD8+ T cells. In cyclosporine- or FK506-treated mice, T-cell proliferation was suppressed in the CD4 subset but not in the CD8 subset. On the contrary, T-cell proliferation was significantly reduced in the CD8 subset but not in the CD4 subset in recipient mice treated with rapamycin.
CONCLUSION: The present mouse model using carboxy-fluorescein diacetate succinimidyl ester labeling is simple and fast. It is useful for screening new immunosuppressants and for examining the effect on T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12698107     DOI: 10.1097/01.TP.0000055832.35337.E6

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Intracellular cytokines in blood T cells in lung transplant patients--a more relevant indicator of immunosuppression than drug levels.

Authors:  G Hodge; S Hodge; P Reynolds; M Holmes
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

2.  Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.

Authors:  D L Roelen; V A L Huurman; R Hilbrands; P Gillard; G Duinkerken; P W M van der Meer-Prins; M F J Versteeg-van der Voort Maarschalk; C Mathieu; B Keymeulen; D G Pipeleers; B O Roep; F H J Claas
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

3.  NFAT-dependent and -independent exhaustion circuits program maternal CD8 T cell hypofunction in pregnancy.

Authors:  Emma L Lewis; Rong Xu; Jean-Christophe Beltra; Shin Foong Ngiow; Jordana Cohen; Rahul Telange; Alexander Crane; Deirdre Sawinski; E John Wherry; Paige M Porrett
Journal:  J Exp Med       Date:  2021-12-09       Impact factor: 17.579

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.